Bionano Genomics (BNGO) Capital Expenditures Growth (1y) (2018 - 2026)
Bionano Genomics (BNGO) Capital Expenditures Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.80 Bn | 121.58 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.93 Bn | 44.11 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 33.21 Bn | 31.56 Bn | 1.53 Bn | - |
| 4 | Medline | 32.90 Bn | 30.66 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.25 Bn | 22.81 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 14.08 Bn | 13.51 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.86 Bn | 13.73 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.12 Bn | 11.06 Bn | 736.59 Mn | 21.73% |
| 10 | Bionano Genomics | 12.02 Mn | -1.67 Mn | 3.25 Mn | 95.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.15% |
| Jun 30, 2025 | 328.57% |
| Mar 31, 2025 | -1,369.23% |
| Dec 31, 2024 | -480.35% |
| Jun 30, 2024 | 130.08% |
| Mar 31, 2024 | -92.78% |
| Dec 31, 2023 | -18.96% |
| Sep 30, 2023 | -61.49% |
| Jun 30, 2023 | 69.23% |
| Mar 31, 2023 | -56.73% |
| Dec 31, 2022 | 143.10% |
| Sep 30, 2022 | 1,227.63% |
| Jun 30, 2022 | -1,194.74% |
| Dec 31, 2019 | -93.05% |
| Sep 30, 2019 | 122.22% |
| Jun 30, 2019 | -117.70% |
| Mar 31, 2019 | 153.59% |
| Dec 31, 2018 | 145.80% |